Dennis Watson, VP of Business Development, Travera

Dennis Watson VP of Business Development, Travera

  •  

    Finding the Best Drug for a Specific Cancer: an Update on Travera

    With: Dennis Watson

    In precision oncology, cancer patients are treated with drugs specifically designed to target distinct features of their tumors. Two years ago, Curious Dr. George asked the CEO of Travera how this company is helping more patients benefit from precision oncology. Here, he checks in with Dennis Watson, Vice President of Business Development, to see how Travera’s services have evolved. Curious Dr. George: For too… Read more »